Inventor · Westford, MA, US

William W. Cruikshank

17Patents
5h-index
3Co-inventors
55Inventor score

Filing activity: Dec 13, 1994 → Apr 16, 2009

Most-cited inventions

PatentTitleAreaCited byStatus
US5766866A Lymphocyte chemoattractant factor and uses thereof Emerging Cross-Sectional Technologies 9 Expired
US8153121B2 Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders Human Necessities 9 Expired
US5807712A DNA encoding lymphocyte chemoattractant factor (LCF) and uses thereof Human Necessities 6 Expired
US6699466B1 IL-16 antagonist peptides and DNA encoding the peptides Human Necessities 6 Expired
US6159463A Lymphocyte chemoattractant factor Human Necessities 5 Expired
US6936426B2 Detection of antibody mediated inflammatory auto-immune disorders Human Necessities 3 Expired
US7998681B2 Diagnosis and therapy of antibody-mediated inflammatory auto-immune disorders Human Necessities 2 Expired
US7208149B2 IL-16 antagonist peptides and DNA encoding the peptides Human Necessities 1 Expired
US5965120A Lymphocyte chemoattractant factor and uses thereof Emerging Cross-Sectional Technologies 1 Expired
US6723697B2 IL-16 antagonists Human Necessities 1 Expired
US7019118B2 IL-16 antagonists Human Necessities 0 Expired
US5976522A Lymphocyte chemoattractant factor and uses thereof Emerging Cross-Sectional Technologies 0 Expired
US7914778B2 Methods of treatment using IL-16 antagonist peptides Human Necessities 0 Active
US5869263A Lymphocyte chemoattractant factor and uses thereof Emerging Cross-Sectional Technologies 0 Expired
US8398973B2 Methods and compositions for preventing adhesion Chemistry; Metallurgy 0 Active
US7232801B2 IL-16 antagonists Human Necessities 0 Expired
US7608691B2 Antibodies against IL-16 antagonist peptides Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.